GLP-1 therapies work, but how do we balance clinical effectiveness with lived experience, equity, and long-term support?
Looking forward to discussing this as a keynote panel member at the Society of Behavioral Medicine Annual Meeting in Chicago on 25 April this year.
See you there!
27 days ago